Morpho Labs
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Morpho Labs - overview
Established
2021
Location
Paris, -, France
Primary Industry
Financial Services
About
Based in France and founded in 2021, Morpho Labs operates as a lending pool optimizer that helps improve the capital efficiency of positions on lending pools by matching lenders and borrowers peer-to-peer. In 2022, the company's first product Morpho-Compound was released, a Morpho's Protocol, which introduces several new concepts to DeFi. In June 2026, Morpho Labs raised USD 175 million in series B funding co-led by Ribbit Capital, Andreessen Horowitz, and Paradigm, with participation from Apollo, VanEck, Cathay Capital, Bpifrance Investissement Régions, SBI Holdings, NJJ Capital, Mirana Ventures, HashKey Capital, IOSG Ventures, Prelude Ventures, Wintermute Ventures, Circle Ventures, and Variant. Morpho Labs operates as a lending pool optimizer called Morpho, with its side products Morpho-Compound, Morpho-AAVE, and Morpho DAO.
By using Morpho, one can upgrade their positions on lending protocols such as Compound or AAVE with Peer-to-Peer liquidity. The company's product is available on Instadapp, a DeFi smart-contract wallet. The company plans to use the June 2026 funding to expand its open credit network, deepen integrations with banks, fintechs, and asset managers, and support development of its lending infrastructure.
Current Investors
Alven, Spark Capital, XAnge
Primary Industry
Financial Services
Sub Industries
e-Financial, Accounting/Finance Software
Website
www.morpho.org/
Verticals
Blockchain, FinTech, FinTech
Company Stage
Series B
Total Amount Raised
Subscriber access only
Morpho Labs - financials
| Fiscal Year Ended | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|
| Revenue (USD) | - | - | - |
| % Revenue Growth (YoY) | - | - | - |
| EBITDA (USD) | - | - | - |
| Operating Income (USD) | - | - | - |
| Operating Margin | - | - | - |
| % EBITDA Margin | - | - | - |
| NET Income (USD) | - | - | - |
| % Net Margin | - | - | - |
Morpho Labs - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series B | Completed | Morpho Labs | - | ||||||||
| Unspecified Round | Completed | Morpho Labs | - | ||||||||
| Unspecified Round | Completed | Morpho Labs | - | ||||||||
| Unspecified Round | Completed | Morpho Labs | - | ||||||||
| Seed | Completed | Morpho Labs | - |
Displaying 1 - 5 of 5
Morpho Labs - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.